DOYLESTOWN, PA -- (MARKET WIRE) -- December 07, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced

DOYLESTOWN, PA -- (MARKET WIRE) -- November 07, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced

DOYLESTOWN, PA -- (MARKET WIRE) -- October 17, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced

DOYLESTOWN, PA -- (MARKET WIRE) -- October 10, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced

DOYLESTOWN, PA -- (MARKET WIRE) -- October 03, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, is pleased

DOYLESTOWN, PA -- (MARKET WIRE) -- September 19, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), a bio-medical company that seeks to develop, acquire, and commercialize proprietary medical technology and products for

AMBLER, PA -- (MARKET WIRE) -- July 17, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB) announced today that it has entered into an exclusive distribution agreement for its PAD technology with

AMBLER, PA -- (MARKET WIRE) -- July 06, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), announced the completion of a Worldwide Technology License Agreement with The Procter & Gamble Company (NYSE:

AMBLER, PA -- (MARKET WIRE) -- June 13, 2006 -- QuantRx® BioMedical Corporation (OTCBB: QTXB) announced that FluoroPharma, Inc. (43.4% owned by QuantRx®) has filed its first Investigational New Drug (IND)

AMBLER, PA -- (MARKET WIRE) -- June 01, 2006 -- QuantRx® BioMedical Corporation (OTCBB: QTXB) announced that its shares of common stock are now being quoted on the OTC Bulletin Board.

AMBLER, PA -- (MARKET WIRE) -- March 16, 2006 -- QuantRx Biomedical Corporation (OTC: QTXB), a developer and marketer of diagnostic products, with a strong intellectual property portfolio, announced the completion

AMBLER, PA -- (MARKET WIRE) -- February 23, 2006 -- QuantRx Biomedical Corporation (OTC: QTXB), (formerly known as A-Fem Medical Corporation) announced the completion of a $4.030 million private placement with